Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Testosterone 12.2 mg (delivery 2.5 mg/24 hours) Transdermal patch TheraTech Inc., Salt Lake City, Utah, United States of America Andropatch Dextrose anhydrous 500 mg/mL in 90 mL Solution, infusion McGaw Biomed Limited, Point Chevalier, Auckland Dextrose 50% Iopamidol 40.8% in 50 mL, 100 mL, 200 mL Injection, solution, bag Abbott Laboratories, North Chicago, Illinois, United States of America Iopamidol Iopamidol 61.2% in 50 mL, 75 mL, 100 mL, 150 mL, 200 mL Injection, solution, bag Abbott Laboratories, North Chicago, Illinois, United States of America Iopamidol Iopamidol 75.5% in 50 mL, 75 mL, 100 mL, 125 mL, 150 mL, 175 mL, 200 mL Injection, solution, bag Abbott Laboratories, North Chicago, Illinois, United States of America Iopamidol Permethrin 5% w/w in 30 g Cream, skin PSM Holdings Limited, Wiri, Auckland Lyderm Latanoprost 50 g/mL in 2.5 mL Drops, eye Pharmacia & Upjohn AB., Uppsala, Sweden and Liquid Packaging Inc., Woodstock, Illinois, United States of America Xalatan Zinc oxide 20% w/w in 41.5 g Stocking, medicated Perstorp Pharma, Ideon, Sweden Zipzoc Dated this 30th day of January 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.